Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04916600 · ClinicalTrials.gov registry record · NA

NET Device for Treating Opioid Use Disorder

A NA study of Opioid Use Disorder, sponsored by Wayne State University.

Active
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT04916600 is a NA study of Opioid Use Disorder that is active but no longer recruiting, run by Wayne State University. The registered enrollment target is 108 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04916600, a NA study of Opioid Use Disorder, is active but no longer recruiting, sponsored by Wayne State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

This prospective, randomized, double-blind, parallel-group, sham-controlled, superiority study will evaluate the effectiveness of the NET Device in treating persons with Opioid Use Disorder (OUD) without use of Medications for OUD (MOUD) for persons who have expressed a desire to be opioid abstinent without use of MOUD.

Conditions Studied

Interventions

  • DEVICE NET

Study Locations (1)

Kentucky

  • Isaiah House Treatment Center - Willisburg

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2021-11-24
Est. Completion 2025-12
Phase NA

Sponsor

Wayne State University

163 total trials

What the Registry Record Tells You About NCT04916600

The ClinicalTrials.gov registry entry for NCT04916600 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (98% lower). The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which NET is the first listed.

NCT04916600 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT04916600 about?

NCT04916600 is a clinical study titled "NET Device for Treating Opioid Use Disorder". This prospective, randomized, double-blind, parallel-group, sham-controlled, superiority study will evaluate the effectiveness of the NET Device in treating persons with Opioid Use Disorder (OUD) without use of Medications for OUD (MOUD) for persons who have expressed a desire to be opioid abstinent...

What is the current status of trial NCT04916600?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2021-11-24. Estimated completion is 2025-12.

What conditions does trial NCT04916600 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT04916600?

The interventions under investigation include: NET (DEVICE).

Who is sponsoring clinical trial NCT04916600?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04916600 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.